These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 21083199)

  • 1. Bioanalytical hydrophilic interaction chromatography: recent challenges, solutions and applications.
    Xu RN; Rieser MJ; El-Shourbagy TA
    Bioanalysis; 2009 Apr; 1(1):239-53. PubMed ID: 21083199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of polar metabolites by hydrophilic interaction chromatography--MS/MS.
    Jian W; Xu Y; Edom RW; Weng N
    Bioanalysis; 2011 Apr; 3(8):899-912. PubMed ID: 21510763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.
    Xu RN; Fan L; Rieser MJ; El-Shourbagy TA
    J Pharm Biomed Anal; 2007 Jun; 44(2):342-55. PubMed ID: 17360141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for drug development.
    Hsieh Y
    Curr Drug Discov Technol; 2010 Sep; 7(3):223-31. PubMed ID: 20843291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites.
    Hsieh Y
    J Sep Sci; 2008 May; 31(9):1481-91. PubMed ID: 18428187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of polar drugs in human plasma with liquid chromatography-tandem mass spectrometry.
    Deng P; Chen X; Zhong D
    Bioanalysis; 2009 Apr; 1(1):187-203. PubMed ID: 21083196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of hydrophilic interaction chromatography for the analysis of polar contaminants in food and environmental samples.
    van Nuijs AL; Tarcomnicu I; Covaci A
    J Chromatogr A; 2011 Sep; 1218(35):5964-74. PubMed ID: 21316059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrophilic interaction chromatography (HILIC) for LC-MS/MS analysis of monoamine neurotransmitters.
    Danaceau JP; Chambers EE; Fountain KJ
    Bioanalysis; 2012 Apr; 4(7):783-94. PubMed ID: 22512797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic comparison of sensitivity between hydrophilic interaction liquid chromatography and reversed phase liquid chromatography coupled with mass spectrometry.
    Periat A; Boccard J; Veuthey JL; Rudaz S; Guillarme D
    J Chromatogr A; 2013 Oct; 1312():49-57. PubMed ID: 24034137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of column temperature and mobile phase components on selectivity of hydrophilic interaction chromatography (HILIC).
    Hao Z; Xiao B; Weng N
    J Sep Sci; 2008 May; 31(9):1449-64. PubMed ID: 18435508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-performance hydrophilic interaction liquid chromatography/tandem mass spectrometry for the determination of everolimus in mouse plasma.
    Hsieh Y; Galviz G; Long BJ
    Rapid Commun Mass Spectrom; 2009 May; 23(10):1461-6. PubMed ID: 19350527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophilic interaction liquid chromatography in the separation of a moderately lipophilic drug from its highly polar metabolites--the cardioprotectant dexrazoxane as a model case.
    Kovaříková P; Stariat J; Klimeš J; Hrušková K; Vávrová K
    J Chromatogr A; 2011 Jan; 1218(3):416-26. PubMed ID: 21168142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hydrophilic interaction and reversed-phase liquid chromatography coupled with tandem mass spectrometric detection for the determination of three pharmaceuticals in human plasma.
    Apostolou C; Kousoulos C; Dotsikas Y; Loukas YL
    Biomed Chromatogr; 2008 Dec; 22(12):1393-402. PubMed ID: 18655216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic evaluation of matrix effects in hydrophilic interaction chromatography versus reversed phase liquid chromatography coupled to mass spectrometry.
    Periat A; Kohler I; Thomas A; Nicoli R; Boccard J; Veuthey JL; Schappler J; Guillarme D
    J Chromatogr A; 2016 Mar; 1439():42-53. PubMed ID: 26387791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in hydrophilic interaction chromatography for quantitative analysis of endogenous and pharmaceutical compounds in plasma samples.
    Isokawa M; Kanamori T; Funatsu T; Tsunoda M
    Bioanalysis; 2014 Sep; 6(18):2421-39. PubMed ID: 25384594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HILIC-MS/MS method development for targeted quantitation of metabolites: practical considerations from a clinical diagnostic perspective.
    Rappold BA; Grant RP
    J Sep Sci; 2011 Dec; 34(24):3527-37. PubMed ID: 22084005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single column comprehensive analysis of pharmaceutical preparations using dual-injection mixed-mode (ion-exchange and reversed-phase) and hydrophilic interaction liquid chromatography.
    Kazarian AA; Taylor MR; Haddad PR; Nesterenko PN; Paull B
    J Pharm Biomed Anal; 2013 Dec; 86():174-81. PubMed ID: 24001905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic applications of HILIC-LC-MS.
    Cubbon S; Antonio C; Wilson J; Thomas-Oates J
    Mass Spectrom Rev; 2010; 29(5):671-84. PubMed ID: 19557839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrophilic interaction liquid chromatography-tandem mass spectrometry determination of estrogen conjugates in human urine.
    Qin F; Zhao YY; Sawyer MB; Li XF
    Anal Chem; 2008 May; 80(9):3404-11. PubMed ID: 18348576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 96-well single-pot liquid-liquid extraction, hydrophilic interaction liquid chromatography-mass spectrometry method for the determination of muraglitazar in human plasma.
    Xue YJ; Liu J; Unger S
    J Pharm Biomed Anal; 2006 Jun; 41(3):979-88. PubMed ID: 16533587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.